Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.

@article{Zeller1996IncreaseOM,
  title={Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.},
  author={Wolfgang Zeller and Kai Gutensohn and Marcus Stockschlaeder and Judith Dierlamm and Nicolaus Kr{\"o}ger and Guenther Koehne and Kimberly Hummel and Hartmut Kabisch and H. J. Weh and Peter Kuehnl and Dieter Kurt Hossfeld and A. R. Zander},
  journal={Bone marrow transplantation},
  year={1996},
  volume={17 5},
  pages={709-13}
}
G-CSF (filgrastim) can effectively mobilize peripheral blood progenitor cells (PBPC) when administered during steady-state hematopoiesis. In this single center study, we compared the effectiveness of two different doses of G-CSF on the mobilization of peripheral blood stem cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. A first group including 33 patients received 10 micrograms G-CSF/kg BW per day (group A), whereas a second group comprising 34… CONTINUE READING
19 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…